These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 32397685)

  • 1. Gender-Related Approach to Kidney Cancer Management: Moving Forward.
    Mancini M; Righetto M; Baggio G
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32397685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender-specific risk factors for renal cell carcinoma: a systematic review.
    Lughezzani G; Paciotti M; Fasulo V; Casale P; Saita A
    Curr Opin Urol; 2019 May; 29(3):272-278. PubMed ID: 30855377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gender differences in incidence and outcomes of urothelial and kidney cancer.
    Lucca I; Klatte T; Fajkovic H; de Martino M; Shariat SF
    Nat Rev Urol; 2015 Oct; 12(10):585-92. PubMed ID: 26436686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sexual dimorphism in cancer: insights from transcriptional signatures in kidney tissue and renal cell carcinoma.
    Laskar RS; Li P; Ecsedi S; Abedi-Ardekani B; Durand G; Robinot N; Hubert JN; Janout V; Zaridze D; Mukeria A; Mates D; Holcatova I; Foretova L; Swiatkowska B; Dzamic Z; Milosavljevic S; Olaso R; Boland A; Deleuze JF; Muller DC; McKay JD; Brennan P; Le Calvez-Kelm F; Scelo G; Chanudet E
    Hum Mol Genet; 2021 Apr; 30(5):343-355. PubMed ID: 33527138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
    Rabjerg M
    Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Research advances in Xp11.2 translocation renal cell carcinoma].
    Huang JH; Zhou FJ
    Ai Zheng; 2008 Sep; 27(9):1006-8. PubMed ID: 18799045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes.
    Dobruch J; Daneshmand S; Fisch M; Lotan Y; Noon AP; Resnick MJ; Shariat SF; Zlotta AR; Boorjian SA
    Eur Urol; 2016 Feb; 69(2):300-10. PubMed ID: 26346676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of gender and age on kidney cancer survival: younger age is an independent prognostic factor in women with renal cell carcinoma.
    Rampersaud EN; Klatte T; Bass G; Patard JJ; Bensaleh K; Böhm M; Allhoff EP; Cindolo L; De La Taille A; Mejean A; Soulie M; Bellec L; Christophe Bernhard J; Pfister C; Colombel M; Belldegrun AS; Pantuck AJ; George D
    Urol Oncol; 2014 Jan; 32(1):30.e9-13. PubMed ID: 23422777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of gender in renal cell carcinoma: an analysis of the SEER database.
    Aron M; Nguyen MM; Stein RJ; Gill IS
    Eur Urol; 2008 Jul; 54(1):133-40. PubMed ID: 18160207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gender Differences in Incidence, Diagnosis, Treatments, and Outcomes in Clinically Localized Bladder and Renal Cancer.
    Gul ZG; Liaw CW; Mehrazin R
    Urology; 2021 May; 151():176-181. PubMed ID: 32561364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contemporary epidemiology of renal cell cancer.
    Chow WH; Devesa SS
    Cancer J; 2008; 14(5):288-301. PubMed ID: 18836333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gender discrepancies in the diagnosis of renal cortical tumors.
    Pierorazio PM; Murphy AM; Benson MC; McKiernan JM
    World J Urol; 2007 Mar; 25(1):81-5. PubMed ID: 17066264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age and gender related differences in renal cell carcinoma in a European cohort.
    Hew MN; Zonneveld R; Kümmerlin IP; Opondo D; de la Rosette JJ; Laguna MP
    J Urol; 2012 Jul; 188(1):33-8. PubMed ID: 22578731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex differences in renal cell cancer presentation and survival: an analysis of the National Cancer Database, 1993-2004.
    Woldrich JM; Mallin K; Ritchey J; Carroll PR; Kane CJ
    J Urol; 2008 May; 179(5):1709-13; discussion 1713. PubMed ID: 18343430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology, Risk Assessment, and Biomarkers for Patients with Advanced Renal Cell Carcinoma.
    Attalla K; Weng S; Voss MH; Hakimi AA
    Urol Clin North Am; 2020 Aug; 47(3):293-303. PubMed ID: 32600532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Race and sex disparities in the treatment of older patients with T1a renal cell carcinoma: a comorbidity-controlled competing-risks model.
    Patel HD; Kates M; Pierorazio PM; Allaf ME
    Urol Oncol; 2014 Jul; 32(5):576-83. PubMed ID: 24629500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-existing type-2 diabetes is not an adverse prognostic factor in patients with renal cell carcinoma: a single-center retrospective study.
    Antonelli A; Arrighi N; Corti S; Zanotelli T; Cozzoli A; Cosciani Cunico S; Simeone C
    Urol Oncol; 2013 Oct; 31(7):1310-5. PubMed ID: 22281433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cuproptosis-related modification patterns depict the tumor microenvironment, precision immunotherapy, and prognosis of kidney renal clear cell carcinoma.
    Cai Z; He Y; Yu Z; Hu J; Xiao Z; Zu X; Li Z; Li H
    Front Immunol; 2022; 13():933241. PubMed ID: 36211378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obesity and Kidney Cancer.
    Wilson KM; Cho E
    Recent Results Cancer Res; 2016; 208():81-93. PubMed ID: 27909903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gender determinants of cardiovascular risk factors and diseases.
    Mercuro G; Deidda M; Piras A; Dessalvi CC; Maffei S; Rosano GM
    J Cardiovasc Med (Hagerstown); 2010 Mar; 11(3):207-20. PubMed ID: 19829128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.